PA5-18028

antibody from Invitrogen Antibodies

Targeting: CREB3L4 AIbZIP, ATCE1, CREB3, CREB4, hJAL

Western blot (Data presented on provider website)

Immunohistochemistry (Recommended by provider)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-18028

Provider

Invitrogen Antibodies

Product name

CREB3L4 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

This antibody is tested in Peptide ELISA: antibody detection limit dilution 32,000.

Reactivity

Human

Host

Goat

Isotype

IgG

Vial size

100 µg

Concentration

0.5 mg/mL

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma.

Pu Q, Lu L, Dong K, Geng WW, Lv YR, Gao HD
Journal of mammary gland biology and neoplasia 2020 Mar;25(1):37-50

---

Towards Age-Related Anti-Inflammatory Therapy: Klotho Suppresses Activation of ER and Golgi Stress Response in Senescent Monocytes.

Mytych J, Sołek P, Będzińska A, Rusinek K, Warzybok A, Tabęcka-Łonczyńska A, Koziorowski M
Cells 2020 Jan 21;9(2)

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Figure 2 Expression of proteins involved in the Golgi stress response. Klotho expression was upregulated with pDNA, cells were treated for 72 h with monensin sodium or 168 h with LPS and expression of proteins involved in CREB34L-, HSP47- and TFE3-mediated pathways was evaluated with Western Blot method (A), i.e.,: CREB34L (B), ARF4 (C), HSP47 (D), and TFE3 (E). The bands were quantified and normalized to their corresponding β-actin bands. Bars indicate SD, n = 3, *** p < 0.001, ** p < 0.01, * p < 0.05, no indication - no statistical significance (one-way ANOVA and Dunnett’s a posteriori test).